far away my favorite share in my portfolio. RDSA has been for a while a good investment, great company with high potential. This company takes his responsibility and invest in green and alternative energy.
I'm looking for long entries for my long term portfolio and for that I'm looking at Fib 0,618 and 0,786 aligns with ~13,44 and ~12
On 7/30/2020 both JPMorgan Chase & Co. and Goldman Sachs Group Set Price Target for RNO stocks to €29.00.
If you are interested in an indicator which can deliver accurate buy and sell at a beginning of a candle, not the end of it, like most do, just give me a PM for a trial period. Can be used in every market.
What you see is the close - hullMA (user defined length (source = open)) displayed as an oscillator.
When the red line crosses the green line from below 0 it could mean a short position = (red dot)
When the green line crosses the red line from below 0 it could mean a long position = (green dot)
Gaps tend to be closed before major moves. Expect it to reach 12eu again before closing upside gaps.
If it doesn't close it now there will be a major move on the downside this year to still close it. Just like the Jan '19 gap that got closed in Aug that same year.
First fib to cross is the 0.3 at 18,5eu. After that 22eu. Shell is lacking momentum compared to the AEX.
the daily chart of this market shows that it will experience an uptrend in the next few days but at the same time
it is necessary to be vigilant of the placement of the stop loss and the level of profile to be gained. consequently the reversal of the market towards the opposite direction
please subscribe to receive more analysis
The idea is to stand aside.
Prices are moving inside a channel. Wait to see if the support line will be broken or not.
If the level 62 EUR WILL BE BROKEN, the idea is to go short, otherwise (if the level of 165 will work as support) the idea is to go long.
Fundamental Analysis - just found a new equilibrium in the production
The monthly rates - 40 A320/A321, 6...
ABI has broken and closed above 44.0 level.
taking into consideration a very oversold market and higher low formation,
it looks like bulls are ready to push higher.
next goal is 56.0 level based on structure!
Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/ 2 study to start in September, followed by a Phase 3 study by the end of 2020. If data are positive, regulatory approval could be achieved by the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant to...